Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
Oncology|February 23, 2013
Novel image analysis method using ultrasound elastography for noninvasive evaluation of hepatic fibrosis in patients with chronic hepatitis CKenji Fujimoto, Michio Kato, Masatoshi Kudo, et al.Digestive Diseases (Basel, Switzerland)|December 22, 2012
Risk of hepatocellular carcinoma development in cases of hepatitis C treated by long-term, low-dose PEG-IFNα-2aSatoru Hagiwara, Toshiharu Sakurai, Masahiro Takita, et al.Journal of Gastroenterology|February 7, 2014
Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinomaTadaaki Arizumi, Kazuomi Ueshima, Haruhiko Takeda, et al.Digestive Diseases (Basel, Switzerland)|November 8, 2014
Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrenceMasashi Kono, Tatsuo Inoue, Masatoshi Kudo, et al.Digestive Diseases (Basel, Switzerland)|November 8, 2014
Duration of stable disease is associated with overall survival in patients with advanced hepatocellular carcinoma treated with sorafenibTadaaki Arizumi, Kazuomi Ueshima, Hirokazu Chishina, et al.Oncology|November 20, 2015
Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Single-Center ExperienceYasunori Minami, Tomohiro Minami, Hirokazu Chishina, et al.Digestive Diseases (Basel, Switzerland)|November 8, 2014
Genome-wide profiling of DNA methylation and tumor progression in human hepatocellular carcinomaNaoshi Nishida, Takafumi Nishimura, Takuya Nakai, et al.Oncology|July 10, 2010
Radiofrequency ablation for hepatocellular carcinoma: assistant techniques for difficult casesTatsuo Inoue, Yasunori Minami, Hobyung Chung, et al.Digestive Diseases (Basel, Switzerland)|August 11, 2011
Des-γ-carboxyprothrombin may be a promising biomarker to determine the therapeutic efficacy of sorafenib for hepatocellular carcinomaKazuomi Ueshima, Masatoshi Kudo, Masahiro Takita, et al.Liver Cancer|January 7, 2016
Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular CarcinomaTadaaki Arizumi, Kazuomi Ueshima, Tomohiro Minami, et al.Pageof 7